down arrow

Microbix Biosystems, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA59501P1045
CAD
0.24
-0.06 (-20.0%)

Dec 04

TSE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Rapid Dose Therapeutics Corp.
Avicanna, Inc.
Microbix Biosystems, Inc.
Ceapro, Inc.
Oncolytics Biotech, Inc.
Cardiol Therapeutics, Inc.
FSD Pharma, Inc.
Medicenna Therapeutics Corp.
Sernova Corp.
BriaCell Therapeutics Corp.
Cognetivity Neurosciences Ltd.
Why is Microbix Biosystems, Inc. ?
1
Poor Management Efficiency with a low ROE of 4.89%
  • The company has been able to generate a Return on Equity (avg) of 4.89% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Operating profit has grown by an annual rate 12.97% of over the last 5 years
3
With a fall in Net Sales of -34.79%, the company declared Very Negative results in Jun 25
  • RAW MATERIAL COST(Y) Grown by 25.45% (YoY)
  • DEBT-EQUITY RATIO (HY) Highest at -19.43 %
  • INVENTORY TURNOVER RATIO(HY) Lowest at 1.24%
4
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -19.40%, its profits have fallen by -117.5%
5
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -19.40% returns in the last 1 year, the stock has also underperformed S&P/TSX 60 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Microbix Biosystems, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Microbix Biosystems, Inc.
-100.0%
-0.38
53.77%
S&P/TSX 60
19.1%
1.54
14.62%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
13.12%
EBIT Growth (5y)
12.97%
EBIT to Interest (avg)
1.52
Debt to EBITDA (avg)
0.46
Net Debt to Equity (avg)
-0.31
Sales to Capital Employed (avg)
0.64
Tax Ratio
8.78%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.47%
ROE (avg)
4.89%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.26
EV to EBIT
29.96
EV to EBITDA
13.39
EV to Capital Employed
1.35
EV to Sales
1.42
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.38%
ROE (Latest)
-1.11%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bullish
Bearish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-28What is not working for the Company
RAW MATERIAL COST(Y)

Grown by 25.45% (YoY

DEBT-EQUITY RATIO (HY)

Highest at -19.43 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.24%

NET SALES(Q)

Lowest at CAD 3.47 MM

OPERATING PROFIT(Q)

Lowest at CAD -0.88 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -25.48 %

PRE-TAX PROFIT(Q)

Lowest at CAD -1.64 MM

NET PROFIT(Q)

Lowest at CAD -1.64 MM

EPS(Q)

Lowest at CAD -0.01

Here's what is not working for Microbix Biosystems, Inc.
Net Sales
At CAD 3.47 MM has Fallen at -38.88%
over average net sales of the previous four periods of CAD 5.68 MM
MOJO Watch
Near term sales trend is extremely negative

Net Sales (CAD MM)

Pre-Tax Profit
At CAD -1.64 MM has Fallen at -524.32%
over average net sales of the previous four periods of CAD 0.39 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CAD MM)

Net Profit
At CAD -1.64 MM has Fallen at -570.01%
over average net sales of the previous four periods of CAD 0.35 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CAD MM)

Net Sales
Lowest at CAD 3.47 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CAD MM)

Operating Profit
Lowest at CAD -0.88 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CAD MM)

Operating Profit Margin
Lowest at -25.48 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at CAD -1.64 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CAD MM)

Net Profit
Lowest at CAD -1.64 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (CAD MM)

EPS
Lowest at CAD -0.01
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (CAD)

Debt-Equity Ratio
Highest at -19.43 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio
Lowest at 1.24%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Raw Material Cost
Grown by 25.45% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."